Basketbal Based Motor Cognitive Training Promotes Adolescents' Personal Growth Initiative and Reduces Reliance on AI
NCT07933354, Not applicable, Not yet recruiting, Yunliang Zhang
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Basketbal Based Motor Cognitive Training Promotes Adolescents' Personal Growth Initiative and Reduces Reliance on AI | ClinicalTrials.gov |
| NCT number | NCT07933354 | ClinicalTrials.gov |
| Status | Not yet recruiting | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 106 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | Yunliang Zhang | ClinicalTrials.gov |
| Conditions | Personal Growth Initiative, Reduces Reliance on AI | ClinicalTrials.gov |
| Interventions | Basketball-Based Motor Cognitive Training, Traditional Basketball Training | ClinicalTrials.gov |
| First posted | 2026-11-12 | ClinicalTrials.gov |
| Last updated | 2026-11-12 | ClinicalTrials.gov |
Registered outcomes 3
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Personal Growth Initiative | 0week、6week、12week | The Personal Growth Initiative Scale-II consists of 16 items rated on a 6-point Likert scale ranging from 0 (strongly disagree) to 5 (strongly agree). The PGIS-II scale has four subscales: Resource Utilization (3 items, e.g., "When I try to change myself, I seek help"), Intentional Behavior (4 items, e.g., "I seize every opportunity to grow"), Planning (5 items, e.g., "I set realistic goals for the changes I want to make"), and Readiness for Change (4 items, e.g., "When I am ready to make specific changes in myself, I can recognize it") . Subscale scores are calculated by averaging the item scores for that subscale. The total scale score is calculated by averaging the scores of the four subscales. Higher scores indicate higher levels of PGI and its subscales. | ClinicalTrials.gov |
| Primary | Reduces Reliance on AI | 0week、6week、12week | Dependence on artificial intelligence technology is measured using the Conversational AI Dependence Scale . The scale consists of four dimensions and 20 items: lack of control, withdrawal symptoms, emotional changes, and negative effects. The scale uses a five-point rating scale (1 = strongly disagree, 5 = strongly agree); the higher the total score, the greater the dependence on artificial intelligence technology. | ClinicalTrials.gov |
| Secondary | Critical thinking | 0week、6week、12week | The Chinese revised version of the Critical Thinking Disposition Scale (CTDS), developed by Sosu (2013) , was used. The scale consists of 11 items and includes two dimensions: critical openness (7 items, measuring an individual's openness and acceptance of new perspectives and feedback from others) and reflective skepticism (4 items, measuring an individual's tendency to question and carefully evaluate information rather than blindly accept it). A 5-point Likert scale was used (1 = strongly disagree, 5 = strongly agree); higher scores indicate stronger critical thinking dispositions. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)